Invited talks incl. Q&A: Advanced therapeutic products
| 08:45-09:35 | Formulation approaches for cell and gene therapies Chris Van der Walle, GlaxoSmithKline, United Kingdom |
| 09:35-09:50 | Comparison of different chromatography-based purification strategies for AAV vectors Ruth Rieser, University of Munich, Germany |
| 09:50-10:05 | Formulation of cationic liposomes enhances the immunogenicity of pDNA vaccine against SARS-COV-2 Allegra Peletta, ISPSO, University of Geneva, Switzerland |
| 10:05-10:25 | Question and answer session |
| 10:25-11:15 | Biodrugs and advanced therapy medicinal products: a revolution in medicine Maria Luisa Nolli, NCNbio, Milan, Italy |
Invited talks incl. Q&A: Solid dosage forms
| 08:45-09:35 | Adoption of the MCS concept in the pharmaceutical industry Michael Leane, Bristol-Myers Squibb, New York City, USA/Kendal Pitt, GlaxoSmithKline, Ware, United Kingdom |
| 09:35-10:25 | Process design for innovative drug delivery systems Jukka Rantanen, Department of Pharmacy, University of Copenhagen, Denmark |
| 10:25-11:15 | The importance of understanding the physical and chemical properties of APIs in the digital design of drug products Kevin Roberts, Faculty of Engineering, University of Leeds, United Kingdom |
Short talks: Controlled drug delivery
| 08:45-09:00 | Design and control of a floating gastroretentive drug delivery system made by hot-melt tube extrusion Paul Bebernik, University of Bonn, Germany |
| 09:00-09:15 | A new calcium oral-controlled-release system based on zeolite for prevention of osteoporosis Anna Maria Piras, University of Pisa, Italy |
| 09:15-09:35 | Question and answer session |
| 09:35-09:50 | Spray dried microparticulate drug delivery systems for long-term local osteoarthritis treatment Carlota Salgado, University of Geneva, Switzerland |
| 09:50-10:05 | Tuning the mechanical poreperties and release profile on an antimicrobial peptide from an injectable hydrogel using glycol chitosan James Flynn, University of Limerick, Ireland |
| 10:05-10:25 | Question and answer session |
| 10:25-10:40 | Development of N-acetylcysteine-functionalized microcontainers for degredation of biofilm matrix Stine Egebro Birk, Technical University of Denmark, Lyngby, Denmark |
| 10:40-10:55 | SynBiosys® based long acting injectable miroparticle formulations for large proteins Tanja Henzler, Merck, Darmstadt, Germany |
| 10:55-11:15 | Question and answer session |
Short talks: Preformulation and bioavailability
| 08:45-09:00 | In situ drug amorphization using laser irradiation Nele-Johanna Hempel, University of Copenhagen, Denmark |
| 09:00-09:15 | Understanding the Release of ITZ:HPMCAS Amorphous Solid Dispersions Patrícia Nunes, Hovione, Portugal |
| 09:15-09:35 | Question and answer session |
| 09:35-09:50 | Evaluation of different preprocessing methods of x-ray micro computed tomography images Sebastian Bollmann, Univeristy of Düsseldorf, Germany |
| 09:50-10:05 | Experimental and numerical studies of input parameters calibration for the simulation of the wet granulation process for pharmaceutical use Maroua Rouabah, Claude Bernard University Lyon 1, France |
| 10:05-10:25 | Question and answer session |
| 10:25-10:40 | Amorphous drug-polyelectrolyte nanoparticle complex as a solubility enhancement strategy of poorly-soluble drugs Kunn Hadinoto, Nanyang Techonological University, Singapore |
| 10:40-10:55 | Insight into amorphous solid dispersion dissolution behaviour: laser-diffraction and Raman spectroscopy holding hands Maria Paisana, Hovione FarmaCiencia, Lisbon, Portugal |
| 10:55-11:15 | Question and answer session |
APGI award session
| 11:45-12:15 | to be announced To be determined |
Plenary lecture incl. Q&A
| 12:15-13:15 | Advances in nanotechnology Patrick Couvreur, Faculty of Pharmaceutical Sciences, Paris Sud University, France |
Invited talks incl. Q&A: 3D-printing
| 14:45-15:35 | 3D-printing of medicines and implants: making the formulations work Clive Roberts, School of Pharmacy, University of Nottingham, United Kingdom |
| 15:35-15:50 | Thermoplastic copolyesters: A promising 3D-printing excipient for personalized vaginal inserts Martin Spoerk, RCPE, Graz, Austria |
| 15:50-16:05 | Semi-Solid Extrusion 3D Printing of Orodispersible Films for Veterinary Use Erica Sjöholm, University of Turku, Finland |
| 16:05-16:25 | Question and answer session |
| 16:25-17:15 | 3D printing in an industrial GMP setting Jaedeok Yoo, Aprecia Pharmaceuticals, Blue Ash, OH, USA |
Invited talks incl. Q&A: What´s new in nanotechnology?
| 14:45-15:35 | What‘s needed in nanomedicine? Twan Lammers, Department Nanomedicines and Theranostics, RWTH, Aachen University, Germany |
| 15:35-16:25 | Nanotechnologies for advanced imaging Nathalie Mignet, Chemical and Biological Technologies for Health, Université de Paris, France |
| 16:25-17:15 | Hyperloaded polymeric micelles for chemo and immunotherapy Alexander Kabanov, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA |
Short talks: Tablets and coated tablets
| 14:45-15:00 | Profiling the influence of process parameters on the interfacial properties of bilayer tablets Jan Hendrik Finke, Technical University of Braunschweig, Germany |
| 15:00-15:15 | Evaluation of the performance of an external lubrication system implemented in a compaction simulator Cedrine de Backere, Ghent University, Ghent, Belgium |
| 15:15-15:35 | Question and answer session |
| 15:35-15:50 | Influence of the unloading conditions on capping and lamination during tableting: numerical and experimental study Vincent Mazel, University of Bordeaux, France |
| 15:50-16:05 | Development of Mini-Tablets with SSR-25 Valentine Elezaj, University of Düsseldorf, Germany |
| 16:05-16:25 | Question and answer session |
| 16:25-16:40 | High solids film coating systems: continuous vs. batch processing Christian Mühlenfeld, Ashland Industries Deutschland GmbH, Düsseldorf, Germany |
| 16:40-16:55 | Effect of the compaction parameters on the final structure and properties of a press-coated tablet (Tab-in-Tab): experimental and numerical study of the influence of core and shell dimensions Léo Picart, University of Bordeaux, France |
| 16:55-17:15 | Question and answer session |
Short talks: Pulmonary, nasal and buccal delivery
| 14:45-15:00 | High potency, brittle matrix tacrolimus powders for dry powder for inhalation by thin film freezing Sawittree Sahakijpijarn, University of Texas at Austin, USA |
| 15:00-15:15 | Delivery of beclomethasone dipropionate nanosuspensions via electronic cigarette Luca Casula, University of Cagliari, Italy |
| 15:15-15:35 | Question and answer session |
| 15:35-15:50 | P. aeruginosa biofilm infectred bronchial epithelium as test-system for anti-infective aerosol formulations Claus-Michael Lehr, Saarland University, Saarbrücken, Germany |
| 15:50-16:05 | Evaluation of a novel probiotic nasal spray in human volunteers Filip Kiekens, University of Antwerp, Belgium |
| 16:05-16:25 | Question and answer session |
| 16:25-16:40 | Nanofibers with antibiotics and probiotics for the two-stage therapy of peridontal disease Spela Zupancic, University of Ljubljana, Slovenia |
| 16:40-16:55 | Mucoadhesive films to elicit nanoparticle buccal permeation Javier Morales, University de Chile, Santiago, Chile |
| 16:55-17:15 | Question and answer session |